Ironwood Pharmaceuticals Inc (FRA:I76)
€ 4.14 0.04 (0.98%) Market Cap: 649.16 Mil Enterprise Value: 1.13 Bil PE Ratio: 113.00 PB Ratio: 0 GF Score: 49/100

Ironwood Pharmaceuticals Inc at Bank of America Merrill Lynch Health Care Conference Transcript

May 14, 2019 / 03:00PM GMT
Release Date Price: €8.77 (-3.63%)
Ying Huang
BofA Merrill Lynch, Research Division - Director in Equity Research

Okay. Good morning. Welcome to the Annual Bank of America Merrill Lynch Global Healthcare Conference in Las Vegas. And my name is Ying Huang. I'm the head of biotech equity research here at BofA Merrill Lynch. Welcome, everyone.

And today is the first day, and we'll kick off with our first presenting company, Ironwood Pharma. I'm pleased to have Mark Mallon, Chief Executive Officer of Ironwood; and also Gina Consylman, the CFO of the company, with us.

So with that, I guess we'll use the fireside format. So welcome and -- Mark.

Mark Mallon
Ironwood Pharmaceuticals, Inc. - CEO & Director

Thank you.

Gina R. Consylman
Ironwood Pharmaceuticals, Inc. - CFO, Senior VP & Treasurer

Thank you.

Questions & Answers

Ying Huang
BofA Merrill Lynch, Research Division - Director in Equity Research

So maybe I'll kick off by asking you about LINZESS, obviously, the most

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot